CRDA.L

Croda International Plc
Croda International - Corporate Broker Appointment
6th June 2025, 07:45
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7904L
Croda International PLC
06 June 2025
 

6 June 2025

 

Croda International Plc

 

Corporate Broker Appointment

 

Croda International Plc is pleased to announce the appointment of UBS as joint corporate broker, to work alongside Morgan Stanley, with immediate effect.

 

ENDS



For more information, please contact:
David Bishop, Investor Relations and Corporate Affairs Director
Contact: +44 7823 874428


About Croda

 

Croda is a specialty chemicals company that creates high performance ingredients and solutions principally for Consumer Care and Life Sciences markets. Established 100 years ago in 1925 and headquartered in the UK, Croda is a FTSE 100 company with over 5,800 employees across 94 locations in 36 countries. Revenues in 2024 were £1.6bn. To find out more about Croda visit: www.croda.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGGVNVMGKZG]]>
TwitterFacebookLinkedIn